跳至主要内容
临床试验/ISRCTN18410689
ISRCTN18410689已完成4 期

A double blind-cross-over, parallel, randomized, multicenter study to evaluate the safety and efficacy of LTS035 (Lactosectan) vs placebo in adult subjects with intolerance to certain foods, primarily lactose intolerant

ovintethical Pharma SA0 个研究点目标入组 60 人开始时间: 2021年12月16日最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
60

研究概览

简要总结

2022 Results article in https://pubmed.ncbi.nlm.nih.gov/36076786/ (added 06/01/2023)

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Aged 18 to 64 years with a current or recently reported history of dairy intolerance of at least 1-month duration
  • 2. Caucasian race
  • 3. Willing to sign the informed consent form

排除标准

  • 1. Pregnant or breastfeeding women
  • 2. Unwilling to sign the informed consent form
  • 3. Allergy to one of the product ingredients
  • 4. Cannot to come to the study visits
  • 5. Patients with celiac disease
  • 6. Patients with gastroenteritis
  • 7. Patients with Crohn’s disease
  • 8. Using lactase enzyme tablets or drops
  • 9. Used antibiotics in the last 4 weeks
  • 10. Used laxatives in the last 2 weeks
  • 11. Laxatives used for a colonoscopy within the last 2 weeks
  • 12. Diabetic patients

研究者

发起方
ovintethical Pharma SA

相似试验

Evaluation of Lactosectan versus placebo to compare... | 临床试验